25 July 2012

Roman Reed law - Senate Appropriations Committee

We need your CLICK for CURE again! The next vote is 3 August.  

A few more steps to climb till we succeed
Will you stand up and be counted for AB 1657 (Roman Reed Law) or will you sit idly by as paralysis and suffering happens? 
We weren't born to be paralyzed. We were born to make a difference.
~Roman Reed~

You CAN stand up and be counted by sending a very simple email with one click to the members of the California Senate Appropriation Committee at the bottom of the page.


Your emails have already got us through three committees and the full Assembly. We have this committee, then the full Senate, and finally the Governor's signature. 


We've made great progress, but it's still too early to claim victory. 


Just a quick reminder of what AB1657 (Roman Reed Law) is.



AB 1657 provides annual funding for research of spinal cord injury and related neurological conditions such as ALS, Alzheimer's, Parkinsons', Spinal Muscular Atrophy (SMA) and others by tacking on a one dollar ($1) surcharge on all moving traffic violations.

There is a clear nexus of connection between car crashes and paralysis. According to the Mayo Clinic, auto accidents cause 46% of all spinal cord injuries and 56% of children's SCI paralysis. It is altogether appropriate to fine those who may cause the condition. 

This way we'll be able to one day realize the dream of paralysis cure.

Supported by Lt.Governor Gavin Newsom, the University ofCalifornia, the California Institute for Regenerative Medicine, Bob Klein, Steve Westly, Craig Newmark, Kristi Yamaguchi, Stem Cells Inc., CA Stem Cell Inc., Dr. Hans Keirstead, California Healthcare Institute, Christopher & Dana Reeve Foundation, Dr. Irv Weissman, Sherry Lansing,Dr. Paul Berg, Art Torres, Duane Roth, Stu Gordon, Dr. Shinya Yamanaka, Dr. Os Steward, Dr. Brock Reeve, Dr. Wise Young, Dr. Paul Knoepfler, Bay Bio and the USC School of Politics among many others! 

This campaign is now closed. Thank you all for your support.

No comments:

Post a comment